Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Receivables - Net: 2020-2024

Historic Receivables - Net for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $27.1 million.

  • Burning Rock Biotech's Receivables - Net rose 8.85% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 8.85%. This contributed to the annual value of $27.1 million for FY2024, which is 16.47% up from last year.
  • Burning Rock Biotech's Receivables - Net amounted to $27.1 million in FY2024, which was up 16.47% from $23.3 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Receivables - Net ranged from a high of $27.1 million in FY2024 and a low of $17.2 million during FY2020.
  • For the 3-year period, Burning Rock Biotech's Receivables - Net averaged around $24.2 million, with its median value being $23.3 million (2023).
  • Per our database at Business Quant, Burning Rock Biotech's Receivables - Net increased by 19.63% in 2021 and then decreased by 5.02% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Receivables - Net (MRY) stood at $17.2 million in 2020, then increased by 19.63% to $20.6 million in 2021, then increased by 7.52% to $22.2 million in 2022, then increased by 5.02% to $23.3 million in 2023, then increased by 16.47% to $27.1 million in 2024.
  • Its Receivables - Net stands at $27.1 million for FY2024, versus $23.3 million for FY2023 and $22.2 million for FY2022.